The Role of PPAR Gamma in Systemic Sclerosis
PPAR Research · 2015 · 2015 · 1-12
DOI: 10.1155/2015/124624 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PPAR Research, 2015. Verfasst von Andréa Tavares Dantas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Serviço de Reumatologia do Hospital das Clínicas da Universidade Federal de Pernambuco (HC-UFPE), 50670-901 Recife, PE, Brazil ; Laboratório de Imuno…. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Fibrosis is recognized as an important feature of many chronic diseases, such as systemic sclerosis (SSc), an autoimmune disease of unknown etiology, characterized by immune dysregulation and vascular injury, followed by progressive fibrosis affecting the skin and multiple internal organs. SSc has a poor prognosis because no therapy has been shown to reverse or arrest the progression of fibrosis, representing a major unmet medical need. Recently, antifibrotic effects of PPAR γ ligands have been studied in vitro and in vivo and some theories have emerged leading to new insights. Aberrant PPAR γ function seems to be implicated in pathological fibrosis in the skin and lungs. This antifibrotic effect is mainly related to the inhibition of TGF- β /Smad signal transduction but other pathways can be involved. This review focused on recent studies that identified PPAR γ as an important novel pathway with critical roles in regulating connective tissue homeostasis, with emphasis on skin and lung fibrosis and its role on systemic sclerosis.
Autor:innen und Institutionen
- Serviço de Reumatologia do Hospital das Clínicas da Universidade Federal de Pernambuco (HC-UFPE), 50670-901 Recife, PE, Brazil ; Laboratório de Imunomodulação e Novas Abordagens Terapêuticas da Universidade Federal de P…
- Laboratório de Imunomodulação e Novas Abordagens Terapêuticas da Universidade Federal de Pernambuco (LINAT-UFPE), 50670-901 Recife, PE, Brazil.
- Laboratório de Planejamento e Síntese de Fármacos da Universidade Federal de Pernambuco (LPSF-UFPE), 50670-901 Recife, PE, Brazil.
- Serviço de Reumatologia do Hospital das Clínicas da Universidade Federal de Pernambuco (HC-UFPE), 50670-901 Recife, PE, Brazil.
Zitieren
APA
Dantas, A. T., Pereira, M. C., de Melo Rego, M. J., da Rocha, L. F., Pitta, I. R., Marques, C. D., Duarte, A. L., & Pitta, M. G. (2015). The Role of PPAR Gamma in Systemic Sclerosis. PPAR Research, 2015, 1-12. https://doi.org/10.1155/2015/124624
Vancouver
Dantas AT, Pereira MC, de Melo Rego MJ, da Rocha LF, Pitta IR, Marques CD, et al. The Role of PPAR Gamma in Systemic Sclerosis. PPAR Research. 2015;2015:1-12. doi:10.1155/2015/124624
BibTeX
@article{Dantas2015,
author = {Dantas, Andréa Tavares and Pereira, Michelly Cristiny and de Melo Rego, Moacyr Jesus Barreto and da Rocha, Laurindo Ferreira and Pitta, Ivan da Rocha and Marques, Cláudia Diniz Lopes and Duarte, Angela Luzia Branco Pinto and Pitta, Maira Galdino da Rocha},
title = {The Role of PPAR Gamma in Systemic Sclerosis},
journal = {PPAR Research},
year = {2015},
volume = {2015},
pages = {1--12},
doi = {10.1155/2015/124624}
}
EUVIMED